Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (ACRV)

Q: What does CUSIP 004890109 represent in this 13F holders report?

CUSIP 004890109 is the security identifier for ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2026?

45 institutional investors reported ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 004890109

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 21,402,527
Total 13F value: $38,095,631
Share change: +5,166,519
SEC-reported price per share: $1.78
Number of holders: 45
Value change: +$9,216,470
Number of buys: 26
Number of sells: 12
Shares outstanding: 43,193,792

Security key

004890109

Report period

Q2 2026

Institutions

Top holders

ACRV full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Previous quarter: Q1 2026 Acrivon Therapeutics, Inc. SEC filings Acrivon Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 004890109

Newer quarter: Q3 2026 Previous quarter: Q1 2026

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

Chione Ltd

Comparable rows

2/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 29% 13 rows are not safely comparable across share classes. 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 29%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 2

RA CAPITAL MANAGEMENT, L.P. 29%

Sands Capital Life Sciences Pulse... 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13D/G 3/4/5 13F Director, 10%+ Owner · Company 13D/G 3/4/5 13F	29% Reported 13D/G · 22 Apr 2026	$15,847,529 12,284,906 shares	+$5,016,666	22 Apr 2026
Sands Capital Life Sciences Pulse Fund II, L.P.	13D/G 13D/G	5.3% Reported 13D/G · 30 Jun 2026	$4,693,006 2,289,271 shares	+$341,665	30 Jun 2026
Chione Ltd	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$16,741,549 3,848,632 shares	—	26 Jun 2023
PERCEPTIVE ADVISORS LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$4,159,546 3,104,139 shares	—	30 Apr 2025
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$3,863,366 888,130 shares	—	17 Nov 2022
Peter Kolchinsky	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	$13,018 29,641 shares mixed-class rows	—	17 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

21,402,527

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend